2.Immune Microenvironment Reprogramming: Treatment significantly elevates CD8+ T cell density within tumor-infiltrating lymphocytes (TILs) while reducing immunosuppressive populations (Tregs: ↓28%; MDSCs: ↓34%), indicating intrinsic immune-potentiating effects (15). The gene discussed is CD8A; the disease is neoplasm.